Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inad...

by Ruediger B. Mueller, Michael Spaeth, Cord von Restorff, Christoph Ackermann, Hendrik Schulze-Koops, Johannes von Kempis
Published 2019-03-01

Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort

by Katja Heinimann, Johannes von Kempis, Rafael Sauter, Michael Schiff, Tuulikki Sokka-Isler, Hendrik Schulze-Koops, Rüdiger Müller
Published 2018-03-01

The Value of an Automated Ultrasound System in the Detection of Synovitis

by Ruediger Mueller, Mathias Grunke, Jörg Wendler, Florian Schuch, Karina Hofmann-Preiss, Ina Boettger, Rüdiger Jakobs, Hendrik Schulze-Koops, Johannes von Kempis
Published 2018-04-01

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts

by Ruediger B. Mueller, Caroline Hasler, Florian Popp, Frederik Mattow, Mirsada Durmisi, Alexander Souza, Paul Hasler, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Johannes von Kempis
Published 2019-09-01

Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus

by Sarah Kiener, Camillo Ribi, Irene Keller, Carlo Chizzolini, Marten Trendelenburg, Uyen Huynh-Do, Johannes von Kempis, on behalf of Swiss SLE Cohort Study (SSCS), Tosso Leeb
Published 2021-08-01

Impact of disease activity on health-related quality of life in systemic lupus erythematosus – a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SS...

by Benjamin Chaigne, Carlo Chizzolini, Thomas Perneger, Marten Trendelenburg, Uyen Huynh-Do, Eric Dayer, Thomas Stoll, Johannes von Kempis, Camillo Ribi, for the Swiss Systemic Lupus Erythematosus Cohort Study Group
Published 2017-03-01